Search results
'Cancer broke my back - now I do things to make me smile'
BBC News· 15 hours agoA woman with incurable cancer that broke her back said she had to "change her mindset" and now does...
John J. York opens up about 'very welcoming' return to 'General Hospital' amid cancer battle
USA TODAY via Yahoo News· 5 hours ago"And here I go already, right off the top 'cause I can’t tell you how nice it's been, the support that I've gotten... 2023 that he was diagnosed with myelodysplastic syndrome ...
“General Hospital” star John York returns to set after cancer battle: 'I feel like I had just a...
Entertainment Weekly via Yahoo News· 7 hours agoThe cast and crew greeted York with "Mac Is Back" T-shirts...Everybody has been very welcoming, very...
'General Hospital's John J. York Talks Returning After Cancer Battle
Entertainment Tonight· 14 hours agoGeneral Hospital star John J. York became emotional while discussing his battle with cancer and the...
'General Hospital's John J. York brought to tears as he reflects on fighting cancer and coming back...
Decider· 9 hours agoThe soap opera star, who revealed last fall that he was diagnosed with two cancers — myelodysplastic...
Battling bureaucracy after burn pits: Why are contractors left behind?
Military Times via Yahoo News· 10 hours agoIt was an unusual injury, doctors told him, so they ran some tests. Soon it made more sense. They...
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
Live Science via Yahoo News· 4 days agoJournal of Medicine, provides important insight into secondary cancers that may arise following CAR...
Case study reveals important new details about rare second cancers related to CAR-T therapy
Medical Xpress· 5 days agoThe finding is reported June 13, 2024, in the New England Journal of Medicine. CAR-T therapy is described by many as a new and promising treatment for blood cancers ...
Cardiovascular conditions now the second-highest reimbursement category, Sun Life says
HR Dive· 5 days agoCardiovascular conditions — including congenital heart defects, heart failure, stroke and hypertension — moved into the second spot for stop-loss reimbursements in 2023 for the first time, an ...
ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory...
Morningstar· 4 days agoPfizer Inc. (NYSE: PFE) today announced detailed overall survival (OS) results from the Phase 2 MagnetisMM-3 study of ELREXFIO™ (elranatamab-bcmm) in patients with heavily pretreated relapsed ...